Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist.
about
Oxytocin improves follicular reserve in a cisplatin-induced gonadotoxicity model in rats.Assessment of fertility protection and ovarian reserve with GnRH antagonist in rats undergoing chemotherapy with cyclophosphamideCombination of a GnRH agonist with an antagonist prevents flare-up effects and protects primordial ovarian follicles in the rat ovary from cisplatin-induced toxicity: a controlled experimental animal study.Geridonin and paclitaxel act synergistically to inhibit the proliferation of gastric cancer cells through ROS-mediated regulation of the PTEN/PI3K/Akt pathwayGonadotrophin-releasing hormone agonists for fertility preservation: unraveling the enigma?Synergistic inhibition of colon cancer cell growth with nanoemulsion-loaded paclitaxel and PI3K/mTOR dual inhibitor BEZ235 through apoptosis.Novel treatment for triple-negative breast and ovarian cancer: endogenous opioid suppression of women's cancers.Dieckol, isolated from the edible brown algae Ecklonia cava, induces apoptosis of ovarian cancer cells and inhibits tumor xenograft growth.Protective effect of alpha-lipoic acid in methotrexate-induced ovarian oxidative injury and decreased ovarian reserve in rats.Effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial.GNRH agonists and antagonists in rescue for cyclophosphamide-induced ovarian damage: friend or foe?A Combination of a GnRH Antagonist and Agonist for Fertility Preservation in an Adolescent Female Murine Model.Protective effects of sildenafil citrate administration on cisplatin-induced ovarian damage in rats.The effects of metformin and letrozole on endometrium and ovary in a rat model.
P2860
Q33740096-BBF74388-8F4F-43B6-820A-E2821E170140Q33912179-7868651B-3AEF-4E6E-B088-E86FF6B69803Q36688597-E7873C2E-7EEC-4B01-910F-281D2F11DF14Q37687329-52937A76-58A8-47EE-8964-1EE451E193A3Q39026680-FF71E7CF-83B4-4FE2-BF7B-4533694AAAADQ39735209-8EC0FE0B-1836-4C68-93ED-DFE35A696FF6Q44342789-2BF5DDA5-9C0B-4915-B5BB-E3179A6D8650Q45902645-917666EA-7EA2-4952-8A15-F326ABD3BB53Q47809528-2E3A800B-D35A-43C4-98BE-2C2FD6CBC009Q47886578-8AA4C59B-D0FF-4E92-B2FC-3BA43355CA8DQ50604899-663FC02F-D055-4278-AD31-AA73D7977A23Q50947107-AD6695ED-7444-4B54-A1DF-B2AB0A4B93CFQ51070627-A64E7F4E-1770-484C-9DE7-58F8ECC1C32DQ51436429-C35138E0-5DA9-4B93-90A8-6915F0455A2F
P2860
Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prevention of paclitaxel and c ...... pin-releasing hormone agonist.
@ast
Prevention of paclitaxel and c ...... pin-releasing hormone agonist.
@en
Prevention of paclitaxel and c ...... pin-releasing hormone agonist.
@nl
type
label
Prevention of paclitaxel and c ...... pin-releasing hormone agonist.
@ast
Prevention of paclitaxel and c ...... pin-releasing hormone agonist.
@en
Prevention of paclitaxel and c ...... pin-releasing hormone agonist.
@nl
prefLabel
Prevention of paclitaxel and c ...... pin-releasing hormone agonist.
@ast
Prevention of paclitaxel and c ...... pin-releasing hormone agonist.
@en
Prevention of paclitaxel and c ...... pin-releasing hormone agonist.
@nl
P2093
P1476
Prevention of paclitaxel and c ...... pin-releasing hormone agonist.
@en
P2093
Ahmet Ozturk
Bulent Ozcelik
Cagdas Turkyilmaz
Cem Batukan
Ibrahim Serdar Serin
Mahmut Tuncay Ozgun
Saim Ozdamar
P304
P356
10.1016/J.FERTNSTERT.2009.02.054
P407
P577
2009-04-01T00:00:00Z